Replies to post #243944 on Biotech Values

[DewDiligence]

OCUL discussion from Evaluate Vantage:

https://www.evaluate.com/vantage/articles/news/trial-results/ocular-therapeutix-joins-long-acting-race

[spongepaul]

I am surprised by the drop in share price as I was very pleased with the results. 80% rescue free @ six months is a success. Many thought 60% would be fantastic.